{"id":"SCV000062127","date_created":"2013-03-16","rcv_accession_id":"RCV000013444","record_status":"current","interpretation_description":"Pathogenic","submitter_id":"21766","clinical_assertion_observation_ids":["SCV000062127.0"],"variation_id":"12610","submitted_assembly":"GRCh37","interpretation_date_last_evaluated":"2014-09-23","submission_id":"21766.2019-03-21","clinical_assertion_trait_set_id":"SCV000062127","interpretation_comments":["{\"text\":\"The Thr58Ile variant in HRAS has been reported in three individuals with clinica l features of Costello syndrome (Gripp 2008, Gripp 2012, LMM unpublished data). It was identified to occur de novo in two of these individuals and segregated w ith disease in one affected relative from one of these families. This variant wa s absent from large population studies. Computational prediction tools and conse rvation analysis suggest that this variant may impact the protein, though this i nformation is not predictive enough to determine pathogenicity. In summary, this variant meets our criteria to be classified as pathogenic (http://pcpgm.partner s.org/LMM).\"}"],"content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"LMM Criteria\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"24033266\",\"@Source\":\"PubMed\"}}},\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"18247425\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"22488832\",\"@Source\":\"PubMed\"}}]}}","local_key":"26351883|Orphanet:ORPHA3071","variation_archive_id":"VCV000012610","internal_id":"103327","version":"5","date_last_updated":"2019-08-30","assertion_type":"variation to disease","trait_set_id":"3420","review_status":"criteria provided, single submitter","submission_names":["SUB5348977"]}
{"id":"SCV000591088","date_created":"2017-08-25","rcv_accession_id":"RCV000500538","record_status":"current","interpretation_description":"Uncertain significance","submitter_id":"506152","clinical_assertion_observation_ids":["SCV000591088.0"],"variation_id":"156482","submitted_assembly":"GRCh37","interpretation_date_last_evaluated":"2013-11-15","submission_id":"506152.2019-04-05","clinical_assertion_trait_set_id":"SCV000591088","interpretation_comments":[],"content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ACMG Guidelines, 2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"25741868\",\"@Source\":\"PubMed\"}}}}","local_key":"NM_000038.5:c.1744-2A\u003eG|not specified","variation_archive_id":"VCV000156482","internal_id":"1147532","version":"2","date_last_updated":"2019-08-03","assertion_type":"variation to disease","trait_set_id":"9590","review_status":"criteria provided, single submitter","submission_names":[]}
{"id":"SCV000189872","date_created":"2014-10-17","rcv_accession_id":"RCV000144573","record_status":"current","interpretation_description":"Pathogenic","submitter_id":"505209","clinical_assertion_observation_ids":["SCV000189872.0"],"variation_id":"156482","interpretation_date_last_evaluated":"2014-07-24","submission_id":"505209.2014-08-08","clinical_assertion_trait_set_id":"SCV000189872","interpretation_comments":[],"content":"{\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"8990002\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"9298819\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"11247896\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"15459959\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"20564245\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"23159591\",\"@Source\":\"PubMed\"}}]}}","local_key":"NM_000038.5:c.1744-2A\u003eG|OMIM:175100","variation_archive_id":"VCV000156482","internal_id":"337561","version":"1","date_last_updated":"2019-08-03","assertion_type":"variation to disease","trait_set_id":"6265","review_status":"no assertion criteria provided","submission_names":[]}
{"id":"SCV000552754","date_created":"2017-04-13","rcv_accession_id":"RCV000144573","record_status":"current","interpretation_description":"Pathogenic","submitter_id":"500031","clinical_assertion_observation_ids":["SCV000552754.0"],"variation_id":"156482","submitted_assembly":"GRCh37","interpretation_date_last_evaluated":"2016-05-27","submission_id":"500031.2017-03-14","clinical_assertion_trait_set_id":"SCV000552754","interpretation_comments":["{\"text\":\"This sequence change affects an acceptor splice site in intron 14 of the APC gene. It is expected to disrupt mRNA splicing and likely results in an absent or disrupted protein product. Truncating variants in APC are known to be pathogenic. This particular truncation has been reported in the literature in many individuals and family affected with familial adenomatous polyposis (FAP) and has been found to segregate with disease in at least one family (PMID: 8990002, 11247896, 15459959, 20223039, 20564245, 9298819). Experimental studies have shown that this change promotes aberrant splicing, leading to the production of an alternative APC transcript lacking exon 14 and low-molecular-weight APC proteins (PMID: 15459959, 9298819). For these reasons, this variant has been classified as Pathogenic.\"}"],"content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Invitae Variant Classification Sherloc (09022015)\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"28492532\",\"@Source\":\"PubMed\"}}}}","local_key":"794579|MedGen:C2713442","variation_archive_id":"VCV000156482","internal_id":"1065662","version":"2","date_last_updated":"2019-08-03","assertion_type":"variation to disease","trait_set_id":"6265","review_status":"criteria provided, single submitter","submission_names":["2017March_Invitae"]}
